News | Defibrillator Monitors | July 28, 2023

GE HealthCare Recalls TruSignal SpO2 Sensors for Issues That May Reduce Defibrillation Energy, Expose Patients to Unintended Voltage, or Give Inaccurate Readings

GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider

GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider

July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider, which could prevent delivery of lifesaving therapy in a critical situation. This issue is most hazardous to hospitalized patients who may need defibrillation for cardiac arrest. Affected sensors may also unintentionally expose patients to electrical currents from other sources or may provide inaccurate measurements of SpO2, which can impact treatment decisions.  

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. 

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. 

Recalled Product  

Product Names:  

  • TruSignal Adult Pediatric Sensor  
  • TruSignal AllFit Sensor  
  • TruSignal Sensitive Skin Sensor  
  • TruSignal Wrap Sensor 
  • TruSignal Ear Sensor  
  • TruSignal Integrated Ear Sensor with GE Connector  
  • TruSignal Integrated Ear Sensor with Datex Connector  
  • TruSignal Integrated Ear Sensor with Datex Connector  
  • TruSignal Integrated Ear Sensor with Ohmeda Connector  

Distribution Dates: January 1, 2021 to March 4, 2023 

Devices Recalled in the U.S.: 7,559 

Date Initiated by Firm: May 19, 2023 

Device Use 

TruSignal sensors continuously monitor the amount of oxygen found in the blood flowing through the arteries (arterial oxygen saturation or SpO2) and pulse rate through a sensor placed on the skin. The sensors are designed and tested to help ensure patients have enough oxygen in their blood to keep their bodies functioning and to give care providers information to make treatment decisions.    

Reason for Recall  

GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to the heart during defibrillation without any notification to the care provider, which could prevent delivery of lifesaving therapy in a critical situation. This issue is most hazardous to hospitalized patients who may need defibrillation for cardiac arrest. Affected sensors may also unintentionally expose patients to electrical currents from other sources or may provide inaccurate measurements of SpO2, which can impact treatment decisions.  

Use of defective TruSignal SpO2 Sensors may cause serious injuries or death.  

GE HealthCare has received four reported injuries and no reported deaths for this issue.  

Who May be Affected  

  • Adults and children whose SpO2 and pulse rate are continuously monitored using TruSignal SpO2 sensors.  
  • Healthcare providers who use TruSignal SpO2 sensors to monitor adult and pediatric patients.  

What to Do  

On May 19, 2023 GE HealthCare sent affected customers an Urgent Medical Device Correction notice with the following recommended actions: 

  • Use an alternate method for SpO2 monitoring, including TruSignal Sensors not impacted or an alternate SpO2 device. 
  • If alternate methods are not available, use affected TruSignal SpO2 Sensors as long as they have not been saturated with fluids. 
  • Follow the below instructions if defibrillation is necessary when affected TruSignal SpO2 Sensors are being used:  
    • Remove the affected TruSignal SpO2 Sensor 
    • Defibrillate per hospital protocol  
    • Reattach the affected TruSignal SpO2 Sensor after defibrillation is no longer needed  
  • Confirm the Adult/Pediatric SpO2 sensors do not have material covering the emitter or detector before using.  
  • Discard the sensor and use another sensor if any additional material is found to be present. 
  • Make sure all potential users are made aware of this safety notification and the recommended actions, and retain this notice.  
  • Complete and return the acknowledgement form attached to the notice to [email protected].  

Contact Information  

Customers with questions or concerns should contact GE HealthCare Service at 1-800-437-1171 or their local service representative.  

Additional Resources:  

Medical Device Recall Database entry: TruSignal Adult Pediatric Sensor  

Medical Device Recall Database entry: TruSignal AllFit SensorExternal Link Disclaimer  

Medical Device Recall Database entry: TruSignal Sensitive Skin Sensor  

Medical Device Recall Database entry: TruSignal Wrap Sensor 

Medical Device Recall Database entry: TruSignal Ear Sensor  

Medical Device Recall Database entry: TruSignal Integrated Ear Sensor with GE Connector 

Medical Device Recall Database entry: TruSignal Integrated Ear Sensor with Datex Connector  

Medical Device Recall Database entry: TruSignal Integrated Ear Sensor with Datex Connector  

Medical Device Recall Database entry: TruSignal Integrated Ear Sensor with Ohmeda Connector  

How do I report a problem? 

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online form or call 1-800-332-1088 for more information on how to mail or fax the form.


Related Content

News | FDA

November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...

Home November 20, 2023
Home
News | FDA

November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 17, 2023
Home
News | FDA

November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U ...

Home November 08, 2023
Home
News | FDA

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow ...

Home November 07, 2023
Home
News | FDA

October 4, 2023 — Anumana, Inc., a leading AI-driven health technology and nference portfolio company working in ...

Home October 04, 2023
Home
News | FDA

October 3, 2023 — EnCompass Technologies, Inc., a privately held medical device company focused on protecting patients ...

Home October 03, 2023
Home
News | FDA

September 27, 2023 — Boston Scientific announced the FDA clearance of the AVVIGOTM+ Multi-Modality Guidance System, a ...

Home September 27, 2023
Home
News | FDA

August 18, 2023 — The U.S. Food and Drug Administration (FDA) announced that Abiomed is recalling the labeling for ...

Home August 18, 2023
Home
News | FDA

August 15, 2023 — Argus Cognitive, Inc., a digital health company that develops software medical devices, announced that ...

Home August 15, 2023
Home
Subscribe Now